Today: 11 June 2026
Lam Research stock drops 3%, then nudges higher after-hours as Wall Street lifts targets
14 January 2026
1 min read

Lam Research stock drops 3%, then nudges higher after-hours as Wall Street lifts targets

New York, Jan 13, 2026, 18:12 EST — After-hours

  • Lam Research shares dropped 2.7% during regular trading but nudged up slightly in after-hours.
  • This week, Bank of America and Bernstein raised their price targets in separate notes
  • Investors are eyeing Lam’s earnings call on January 28, covering the December quarter

Lam Research (LRCX) shares dropped 2.7% on Tuesday but edged higher in after-hours trading. Bank of America and Bernstein raised their price targets for the chipmaking equipment company. The stock finished the day at $214.38 and gained roughly 0.6% after the close.

The retreat followed Lam’s shares hitting a 52-week high just a day earlier, leaving the stock trailing behind major rivals as the broader market dipped. Applied Materials slipped 0.8%, while the S&P 500 edged down 0.2%, according to MarketWatch data.

Why it matters now: the stock has surged through late January, prompting investors to question if the rally is outpacing the upcoming order cycle. Zacks noted Lam’s gains are fueled by strength in 3D DRAM and advanced packaging but cautioned that spending on mature chip nodes might remain weak, with ongoing U.S.-China trade tensions posing a threat.

Tuesday’s trading was volatile. Lam kicked off at $219.42, hitting a peak of $222.40 before dipping to $213.44. Roughly 12.7 million shares exchanged hands, per market data.

Bank of America’s analyst Vivek Arya bumped the price target to $245 from $195 while maintaining a buy rating, TheFly reports. The upgrade reflects a “stronger multi-year demand outlook” and the chance for increased free cash flow as the cycle shifts. TipRanks

Bernstein raised its price target to $225 from $175 and kept an outperform rating. The firm pointed to a possible “NAND upgrade cycle starting,” signaling renewed spending on flash memory production, which often drives demand for new etch and deposition equipment. TipRanks

Lam is a key player in wafer fabrication equipment, focusing on deposition and etch processes — applying thin layers to chips and then selectively removing material to create circuits. Its tools see heavy use in memory chip manufacturing, making the company’s performance closely tied to fluctuations in DRAM and NAND investments.

Lam’s upcoming earnings call for the December 2025 quarter is set for Jan. 28. Investors will zero in on management’s take on memory spending, potential momentum in a NAND upgrade cycle, and whether the guidance backs the recent spike in targets.

That said, the situation is double-edged. Any sign of caution in orders, slowing customer spending, or margin pressure could weigh on a stock hovering near its recent peaks.

Looking ahead to the next session, the key question is if the after-hours bounce sticks and if additional brokers update their targets. The bigger test arrives Jan. 28, when Lam releases its outlook amid a market that’s already factoring in stronger demand.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Google stock (GOOG) rises after-hours on Apple’s Gemini-Siri deal as earnings near
Previous Story

Google stock (GOOG) rises after-hours on Apple’s Gemini-Siri deal as earnings near

Nvidia stock braces for a China shock as customs blocks H200 AI chips despite U.S. export nod
Next Story

Nvidia stock braces for a China shock as customs blocks H200 AI chips despite U.S. export nod

Go toTop